Out of stock
AED60.50
Overview
|7 transdermal therapeutic systems 20 cm2 |Mean release of active substance nicotine on the skin is 14 mg/24 hours |35 mg Nicotine per transdermal patch |Sustained release
- 7 transdermal therapeutic systems 20 cm2
- Mean release of active substance nicotine on the skin is 14 mg/24 hours
- 35 mg Nicotine per transdermal patch
- Sustained release
- Nicotinell 35 mg TTS 20 Transdermal Patch contains 35 mg Nicotine per transdermal patch which provides a consistent supply of nicotine for 24 hours. Nicotinell TTS is intended for adults aged 18 years old and over. The dosage is dependent on the patient's nicotine requirements needed for reducing withdrawal symptoms. The total duration of treatment is limited to three months but vary as a function of individual response.
- Patch can help curb those intense morning cravings and help you stop smoking
- Prevents nicotine withdrawal symptoms associated with tobacco dependence
- Safer alternative to smoking for smokers and those around them
- Convenient than nicotin chewing gums
- One Nicotinell TTS is applied daily and left on the skin for 24 hours.
- Nicotine Patch contains aluminium. It should therefore be removed during MRI investigations, electric defibrillation and diathermy treatment.
| Brand | Nicotinell |
|---|---|
| Height in cm (Final Packing) | 10 |
| Length in cm (Final Packing) | 10 |
| Width in cm (Final Packing) | 2 |
| Gender | Unisex |
| Life Stage | Adult |
| Form | Patch |
| Quantity Per Pack | 7 |
| Country of Origin | Switzerland |
| Manufacturer | LTS Lohman For GSK Consumer Healthcare |
| Pack Specification | Box |
| Usage | Transdermal |
| Storage Temperature | Cool Temperature |
Write Your Own Review